Yupingfeng San ameliorates lipopolysaccharide-induced acute intestinal inflammation via modulation of the MAPK/apoptosis signaling pathway

Authors: Tang, Yuxi; Wang, Chenying; Feng, Shuo; Qi, Lanzhen; Liang, Wenping; Jiang, Wenjie; Bi, Shicheng; Ma, Qi

Source journal: Journal of ethnopharmacology (2026-11-17)

DOI: 10.1016/j.jep.2026.122626

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: Yupingfeng San (YPFS) is a traditional Chinese medicine formulation traditionally used to tonify Wei Qi and consolidate the exterior. Its anti-inflammatory and immunomodulatory activities provide a pharmacological basis for investigation in inflammation. AIM OF THE STUDY: This study investigated the protective effects and underlying mechanisms of YPFS against lipopolysaccharide (LPS)-induced acute intestinal inflammation using network pharmacology, transcriptomics, molecular docking, and in vivo experiments. MATERIALS AND METHODS: Putative active compounds, targets, and pathways were identified by network pharmacology and enrichment analysis. An LPS-induced acute intestinal inflammation mouse model was established, and clinical, histopathological, inflammatory, transcriptomic, and molecular outcomes were evaluated. MAPK- and apoptosis-associated changes were examined by RT-qPCR and Western blotting. RESULTS: Network analysis identified quercetin, decursin, astragaloside IV, ledebouriellol A, and formononetin as key compounds, with Tnf, Mapk1, Mapk3, Il1b, and Casp3 as core targets. YPFS pretreatment improved clinical manifestations, reduced DAI and organ indices, alleviated colonic injury, and improved goblet-cell loss. YPFS reduced IL-1beta and TNF-alpha, increased IL-4 and IL-10, and improved ZO-1 and Occludin mRNA expression. Transcriptomic and qRT-PCR analyses indicated that YPFS modulated MAPK- and apoptosis-associated gene expression. Western blotting further showed reduced LPS-associated ERK and JNK phosphorylation and attenuation of apoptosis-associated protein changes, including BAX, BCL-2, and Cleaved-caspase-3. CONCLUSIONS: YPFS attenuated LPS-associated acute intestinal inflammatory injury and inhibited aberrant MAPK signaling, accompanied by attenuation of apoptosis-associated molecular changes and improvement of barrier-associated morphological and transcriptional alterations. These findings support the potential involvement of the MAPK/apoptosis axis in the protective effects of YPFS.

Read the full text

Related topics

Related open access articles

Abstract and bibliographic data from PubMed (U.S. National Library of Medicine). Copyright of the abstract belongs to the original publisher or authors.